Pharmaceuticals giant Pfizer Inc. (
) on Tuesday posted better-than-expected adjusted fourth quarter
earnings, but lowered its full-year 2012 outlook due to currency
translation effects stemming from a stronger dollar.
The New York-based company reported fourth quarter net income of
$1.44 billion, or 19 cents per share, compared with $2.89 billion,
or 36 cents per share, in the year-ago period. Excluding one-time
items, adjusted profit was 50 cents per share.
Revenue declined 4% from last year to $16.75 billion.
On average, Wall Street analysts expected a smaller profit of 47
cents per share, on lower revenue of $16.61 billion.
Looking ahead, the company lowered its 2012 adjusted earnings
forecast to a range of $2.20 to $2.30 per share, down 5 cents from
its prior estimate of $2.25 to $2.35.
Pfizer shares posted modest losses in premarket trading
The Bottom Line
Shares of Pfizer (
) have a 4.08% dividend yield, based on last night's closing stock
price of $21.58. The stock has technical support in the $19 price
area. If the shares can firm up, we see overhead resistance around
the $22-$24 price levels.
Pfizer Inc. (
) is not recommended at this time, holding a Dividend.com DARS™
Rating of 3.4 out of 5 stars.
Be sure to visit our complete recommended list of the
Best Dividend Stocks
, as well as a detailed explanation of
our ratings system here
Created by Dividend.com